4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-024494
Chief Commercial Officer sold 8,925 shares at $35.31 ($315,142)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Oliver Tracie Chief Commercial Officer | 2023-07-03 | Sale | −8,925 | $35.31 | $315,142 | 61,575 | D |
| Open-market sales · 8,925 sh · avg $35.31 · $315,142 | |||||||
Loading xslF345X04/wk-form4_1688681055.xml…